GT Medical, a leading Saudi MedTech and Pharma company, has successfully raised $100.0M in a Series E funding round. The capital infusion marks a significant step for the firm, which was founded in 2005 and is known for its extensive operations across Saudi Arabia.
Backed by a robust holding group, GT Medical has expressed ambitions to expand its business footprint and continue its mission of providing innovative health solutions throughout the region. The company prides itself on a culture of professionalism and integrity, which has underpinned its growth since its inception.















